Antiviral-Metal Complexes for Treatment of Influenza Virus Infections ID: 2014-090
A novel composition of antiviral drugs and metal complexes designed to enhance the treatment of influenza by blocking viral replication.
Photo by starlineart - stock.adobe.com
Technology Overview
This technology introduces a groundbreaking approach to influenza treatment by combining antiviral drugs with metal complexes. The metal ions specifically target and bind to clusters within the influenza virus, inhibiting proton transport and stabilizing the drug within the virus's channel. This mechanism effectively prevents the virus from replicating, offering a potent means to combat influenza, including strains that have developed resistance to existing treatments.
Key Advantages
- Enhanced efficacy against various influenza strains, including drug-resistant mutations
- Improved drug stability within the viral channel
- Reduced toxicity compared to existing treatments
- Potential for broad-spectrum antiviral applications beyond influenza
Problems Addressed
- Drug stability issues in current influenza treatments
- Channel occlusion challenges in the treatment process
- Inefficacy against strains with mutations
Market Applications
- Pharmaceutical development for new influenza treatments
- Research tools for studying influenza virus and drug interactions
- Potential expansion into treatments for other viral infections leveraging similar mechanisms
Additional Information
Technology ID: 2014-090
Sell Sheet: Download the Sell Sheet here
Market Analysis: Contact us for a more in-depth market report
Date Published: 07 May, 2025
Connect with the Tech Transfer to:
- Meet with the technology manager
- Receive additional information
- Request a marketing plan report